Press Release
SparingVision Presents New Data on SPVN20 Program at ASGCT 2023
SparingVision Presents New Data on SPVN20 Program at ASGCT 2023 First oral presentation on SPVN20…
SparingVision to Highlight Progress of its SPVN20 Program in oral presentation at ASGCT 2023
SparingVision to Highlight Progress of its SPVN20 Program in oral presentation at ASGCT 2023 Paris,…
SparingVision Presents Progress of its Lead Gene Therapy Program SPVN06 at ARVO 2023
SparingVision Presents Progress of its Lead Gene Therapy Program SPVN06 at ARVO 2023 Paris, April…
SparingVision receives final tranche payment from the European Investment Council as part of the EIC Accelerator Program
SparingVision receives final tranche payment from the European Investment Council as part of the EIC…
SparingVision to Highlight Progress of its Lead Gene Therapy Program SPVN06 and Research on Retinitis Pigmentosa at ARVO 2023
SparingVision to Highlight Progress of its Lead Gene Therapy Program SPVN06 and Research on Retinitis…
SparingVision appoints Joseph C. Papa as Chairman
SparingVision appoints Joseph C. Papa as Chairman Former Bausch and Lomb Chairman and CEO joins…